UB Paderborn / Katalog / Suche / in CDI

α-Bungarotoxin Binding to Acetylcholine Receptor Membranes Studied by Low Angle X-Ray Diffraction

Biophysical journal, 2003-08, Vol.85 (2), p.943-953

2003

Link zum Volltext

Verfügbarkeit prüfen

Lercanidipine: Short Plasma Half-Life, Long Duration of Action: A Molecular Model to Rationalize Its Pharmacokinetic Properties

Journal of cardiovascular pharmacology, 1997, Vol.29 Sup 1 (Sup 1), p.S19-S24

1997

Link zum Volltext

Verfügbarkeit prüfen

Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol

Neurobiology of aging, 1992-05, Vol.13 (3), p.413-419

1992

Link zum Volltext

Verfügbarkeit prüfen

Molecular interaction between lacidipine and biological membranes

Journal of hypertension, 1993-03, Vol.11 Suppl 1 (1), p.S13-S19

1993

Link zum Volltext

Verfügbarkeit prüfen

X-ray Diffraction Analysis of Cytochrome P450 2B4 Reconstituted into Liposomes

Biochemistry (Easton), 1996-02, Vol.35 (5), p.1466-1474

1996

Link zum Volltext

Verfügbarkeit prüfen

The Molecular Basis for Lacidipineʼs Unique Pharmacokinetics: Optimal Hydrophobicity Results in Membrane Interactions That May Facilitate the Treatment of Atherosclerosis

Journal of cardiovascular pharmacology, 1994, Vol.23 Suppl 5, p.S16-S25

1994

Link zum Volltext

Verfügbarkeit prüfen

Reevaluating equilibrium and kinetic binding parameters for lipophilic drugs based on a structural model for drug interaction with biological membranes

Journal of medicinal chemistry, 1991-03, Vol.34 (3), p.869-877

1991

Link zum Volltext

Verfügbarkeit prüfen

Reevaluating equilibrium and kinetic binding parameters for lipophilic drugs based on a structural model for drug interactions with biological membranes

Journal of medicinal chemistry, 1991-03, Vol.34 (3), p.869-877

1991

Link zum Volltext

Verfügbarkeit prüfen

(Alpha)-Bungarotoxin binding to acetylcholine receptor membranes studied by low angle x-ray diffraction

Biophysical journal, 2003-08, Vol.85 (2), p.943

2003

Link zum Volltext

Verfügbarkeit prüfen

Interaction of 1,4 dihydropyridine calcium channel antagonists with biological membranes: Lipid bilayer partitioning could occur before drug binding to receptors

Journal of molecular and cellular cardiology, 1989-02, Vol.21 (2), p.187-201

1989

Link zum Volltext

Verfügbarkeit prüfen

Phospholipid fatty acyl chain asymmetry in the membrane bilayer of isolated skeletal muscle sarcoplasmic reticulum

Biochemistry (Easton), 1987-07, Vol.26 (15), p.4831-4836

1987

Link zum Volltext

Verfügbarkeit prüfen

Membrane pathways for drug/ion channel interactions: Molecular basis for pharmacokinetic properties

Drug development research, 1994-11, Vol.33 (3), p.214-224

Herbette, Leo G.

1994

Link zum Volltext

Verfügbarkeit prüfen

XaRay Diffraction Analysis of Brain Lipid Membrane Structure in Alzheimer's Disease and I2aAmyloid Peptide Interactionsa

Annals of the New York Academy of Sciences, 1993-09, Vol.695 (1), p.54-58

1993

Link zum Volltext

Verfügbarkeit prüfen

X-Ray Diffraction Analysis of Brain Lipid Membrane Structure in Alzheimer's Disease and β-Amyloid Peptide Interactions

Annals of the New York Academy of Sciences, 1993-09, Vol.695 (1), p.54-58

1993

Link zum Volltext

Verfügbarkeit prüfen

Study of the topography of cannabinoids in model membranes using X-ray diffraction

Biochimica et biophysica acta, 1990-05, Vol.1024 (2), p.336-344

1990

Link zum Volltext

Verfügbarkeit prüfen

X‐Ray Diffraction Analysis of Brain Lipid Membrane Structure in Alzheimer's Disease and β‐Amyloid Peptide Interactionsa

Annals of the New York Academy of Sciences, 1993-09, Vol.695 (1), p.54-58

1993

Link zum Volltext

Verfügbarkeit prüfen

Possible molecular basis for the pharmacokinetics and pharmacodynamics of three membrane-active drugs: Propranolol, nimodipine and amiodarone

Journal of molecular and cellular cardiology, 1988-05, Vol.20 (5), p.373-378

1988

Link zum Volltext

Verfügbarkeit prüfen

Can altering serum cholesterol affect neurologic function?

Journal of molecular and cellular cardiology, 1991-11, Vol.23 (11), p.1339-1342

1991

Link zum Volltext

Verfügbarkeit prüfen

Cholesterol significantly affects drug interactions with membranes

Pharmacochemistry Library, 1997, Vol.28, p.117-125

Herbette, Leo G.

1997

Link zum Volltext

Verfügbarkeit prüfen

Single crystal X-ray structures of the two 4-heptadecyl derivatives of (1 R,5 S)-3,6,8-trioxabicylo[3.2.1]octane

Chemistry and physics of lipids, 1995-08, Vol.77 (1), p.99-112

1995

Link zum Volltext

Verfügbarkeit prüfen

'Pharmacokinetic' and 'pharmacodynamic' design of lipophilic drugs based on a structural model for drug interactions with biological membranes

Pesticide science, 1992, Vol.35 (4), p.363-368

Herbette, L.G

1992

Link zum Volltext

Verfügbarkeit prüfen

A molecular model involving the membrane bilayer in the binding of lipid soluble drugs to their receptors in heart and brain

International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1990, Vol.17 (1), p.13-33

1990

Link zum Volltext

Verfügbarkeit prüfen

103 Molecular “Imaging” of Cellular Constituents, Biological Membranes and Small Molecular Structures (Drugs, Toxins and Anesthetics)

Investigative radiology, 1986-09, Vol.21 (9), p.S26

1986

Link zum Volltext

Verfügbarkeit prüfen

Membrane damage and the pathogenesis of cardiomyopathies

Journal of molecular and cellular cardiology, 1985-07, Vol.17, p.11-20

1985

Link zum Volltext

Verfügbarkeit prüfen

The effects of calcium channel blocking drugs on the thermotropic behavior of dimyristoylphosphatidylcholine

Chemistry and physics of lipids, 1989-07, Vol.51 (1), p.1-7

1989

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

α-Bungarotoxin Binding to Acetylcholine Receptor Membranes Studied by Low Angle X-Ray Diffraction

Lercanidipine: Short Plasma Half-Life, Long Duration of Action: A Molecular Model to Rationalize Its Pharmacokinetic Properties

Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol

Molecular interaction between lacidipine and biological membranes

X-ray Diffraction Analysis of Cytochrome P450 2B4 Reconstituted into Liposomes

The Molecular Basis for Lacidipineʼs Unique Pharmacokinetics: Optimal Hydrophobicity Results in Membrane Interactions That May Facilitate the Treatment of Atherosclerosis

Reevaluating equilibrium and kinetic binding parameters for lipophilic drugs based on a structural model for drug interaction with biological membranes

Reevaluating equilibrium and kinetic binding parameters for lipophilic drugs based on a structural model for drug interactions with biological membranes

(Alpha)-Bungarotoxin binding to acetylcholine receptor membranes studied by low angle x-ray diffraction

Interaction of 1,4 dihydropyridine calcium channel antagonists with biological membranes: Lipid bilayer partitioning could occur before drug binding to receptors

Phospholipid fatty acyl chain asymmetry in the membrane bilayer of isolated skeletal muscle sarcoplasmic reticulum

Membrane pathways for drug/ion channel interactions: Molecular basis for pharmacokinetic properties

XaRay Diffraction Analysis of Brain Lipid Membrane Structure in Alzheimer's Disease and I2aAmyloid Peptide Interactionsa

X-Ray Diffraction Analysis of Brain Lipid Membrane Structure in Alzheimer's Disease and β-Amyloid Peptide Interactions

Study of the topography of cannabinoids in model membranes using X-ray diffraction

X‐Ray Diffraction Analysis of Brain Lipid Membrane Structure in Alzheimer's Disease and β‐Amyloid Peptide Interactionsa

Possible molecular basis for the pharmacokinetics and pharmacodynamics of three membrane-active drugs: Propranolol, nimodipine and amiodarone

Can altering serum cholesterol affect neurologic function?

Cholesterol significantly affects drug interactions with membranes

Single crystal X-ray structures of the two 4-heptadecyl derivatives of (1 R,5 S)-3,6,8-trioxabicylo[3.2.1]octane

'Pharmacokinetic' and 'pharmacodynamic' design of lipophilic drugs based on a structural model for drug interactions with biological membranes

A molecular model involving the membrane bilayer in the binding of lipid soluble drugs to their receptors in heart and brain

103 Molecular “Imaging” of Cellular Constituents, Biological Membranes and Small Molecular Structures (Drugs, Toxins and Anesthetics)

Membrane damage and the pathogenesis of cardiomyopathies

The effects of calcium channel blocking drugs on the thermotropic behavior of dimyristoylphosphatidylcholine

Suchergebnisse filtern